SMITHS GROUP SERVICES CORPORATION for SMITHS GROUP SERVICES CORPORATION
What was lobbied
9 issue areas, each in the filer's own words, with who lobbied on it and where.
Energy/Nuclear ENG
Conversations around liquid pipeline safety performance and voluntary standards for mechanical seals.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
Defense DEF
S.2943/H.R.4909, National Defense Authorization Act for Fiscal Year 2017. H.R.5293/S.3000, Department of Defense Appropriations Act, 2017; P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures. Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology and detection solutions for the Department of Defense.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN SCHMIDT | — |
Taxation/Internal Revenue Code TAX
H.R.160, Protect Medical Innovation Act of 2015; S.149, Medical Device Access and Innovation Protection Act. Tax reform; international tax issues; the repeal of the medical device excise tax; manufacturing and taxes.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
| CHRIS SWONGER | — |
Budget/Appropriations BUD
Funding for aviation security and homeland security technologies. S.3001/H.R.5634, Department of Homeland Security Appropriations Act, 2017; Transportation Security Administration (TSA) funding issues. H.R.5293/S.3000, Department of Defense Appropriations Act, 2017; chemical and biological counter measures. S.3040/House Committee Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; medical device funding and policy. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN SCHMIDT | — |
| CHRIS SWONGER | — |
Environment/Superfund ENV
Issues related to climate change and emissions technologies.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
| CHRIS SWONGER | — |
Homeland Security HOM
Issues related to aviation security solutions and detection technologies for the Transportation Security Administration (TSA), Department of Homeland Security (DHS) and U.S. Customs and Border Protection (CBP). Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology and other border security solutions. S.3001/H.R.5634, Department of Homeland Security Appropriations Act, 2017; Transportation Security Administration (TSA) funding issues.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN SCHMIDT | — |
Medical/Disease Research/Clinical Labs MED
H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; H.R.6, 21st Century Cures Act; issues related to patient infusion therapy. Regulations related to Medical Device User Fee Amendments (MDUFA). Issues related to Medicare reimbursements for tracheotomy tubes.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
| KEVIN SCHMIDT | — |
| CHRIS SWONGER | — |
Torts TOR
H.R.526, Furthering Asbestos Claim Transparency (FACT) Act of 2015; S.357, FACT Act; H.R.1927, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016; issues related to tort reform.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
| CHRIS SWONGER | — |
Aviation/Airlines/Airports AVI
Aviation security solutions and detection technologies for the Transportation Security Administration (TSA).
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN SCHMIDT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.